Boyanov & Co. is well regarded in the healthcare and life sciences space for its stellar client roster of pharmaceutical manufacturers, generics companies and pharmacies. The firm has extensive experience relating to Bulgarian and EU regulations in the pharma sector and is therefore well placed to advise on a broad range of market access issues, intellectual property protection and trade mark registration, patent litigation and commercial disputes regarding the sale of medicines and pharmaceutical price regulation matters. Dispute resolution expert Kina Chuturkova represents pharmaceutical clients in litigation and international arbitration proceedings, while Peter Petrov uses his regulatory and EU law expertise when advising landmark clients such as Pfizer, Merck and AbbVie on an ongoing basis. Nedyalka Novakova further strengthens the team's offering.

Dimitrov, Petrov & Co is highly regarded for its ‘in-depth knowledge of the life sciences sector’ where the team covers a litany of matters that relate to intellectual property, commercial, competition, data protection, corporate and employment law. The team is well placed to provide day-to-day advice to clients such as Pfizer, Johnson & Johnson and Eli Lilly thanks to its expertise in the Bulgarian regulatory framework and market conditions. Furthermore, the team is well regarded for its strength in patent litigation and experience in medical malpractice cases (a specialism of recently promoted partner Encho Simeonov). The practice is led by Zoya Todorova and Martin Zahariev, the latter of whom was promoted to partner in March 2023. Todorova advises pharma and life sciences companies on corporate matters and M&A transactions, while Zahariev leverages his expertise in IP field, among others, to support global life sciences companies. Yana Georgieva is also a key member of the team.

Domestic and international life sciences companies, pharmaceutical manufacturers and retail companies, as well as medical institutions, turn to Djingov, Gouginski, Kyutchukov & Velichkov‘s pharma and healthcare practice group thanks to its broad advisory offering in this sector. Due to the firm’s full-service setup, the team is able to assist clients with matters ranging from day-to-day assistance, project-based legal assistance, commercial agreements, and representation in administrative and litigation proceedings, through to compliance advice on clinical trial agreements. Kalina Tchakarova heads up the practice and is well regarded for her expertise in the field of IP law, and experience advising pharmaceutical companies on medicinal products regulation.

A standout feature of CMS‘ healthcare practice is its experience across Central and Eastern Europe, predominantly in multi-jurisdictional M&A transactions and divestments for pharmaceutical, biotechnology and medical devices clients. In addition, the team's varied caseload includes advice on clinical trials and non-interventional studies, as well as daily legal assistance on regulatory and commercial matters, data protection, marketing and employment queries. Litigation expert Assen Georgiev leads the practice alongside Anna Tanova, who covers various commercial matters pertaining to the life sciences and healthcare industry.

Deloitte Legal Law Firm is well placed to assist national and multinational healthcare and pharmaceutical clients with matters pertaining to tax, accounting, finance and regulatory compliance, due to its ‘diverse and broad legal knowledge’. Practice head Miglena Micheva is well versed in medical law, data privacy and pharma regulations. Further key contacts for this practice are Irena Koleva and Zvezdelina Filova.

Eversheds Sutherland, which merged with local firm Tsvetkova Bebov and Partners in June 2022, assists pharmaceutical and food companies with regard to competition and contract law issues, as well as representing clients in commercial and administrative litigation proceedings. Among the matters the team is regularly instructed on are market access issues, pricing and reimbursement legislation, clinical trial agreements and compliance with regulations. The team is jointly led by Irina Tsvetkova and Eleonora Mateina, the latter of whom is praised for her ‘stunning knowledge of pharmaceutical law’.

Georgiev, Todorov & Co advises hospitals, medical institutions, and pharmaceutical and cosmetic companies on an ongoing basis regarding intellectual property matters, mergers and acquisitions, medical supply agreements and compliance with the regulatory framework. The team led by Ivan Todorov is well versed in healthcare and life sciences-related disputes and administrative proceedings.

Kambourov & Partners' multidisciplinary healthcare, life sciences and pharmaceuticals practice encompasses regulatory and intellectual property advice, data protection and patient confidentiality issues, employment law, and corporate and M&A matters. The firm acts for healthcare providers, pharmaceutical companies, biotechnology firms and start-ups within the healthcare sector. Regulatory expert Ivo Alexandrov and employment and data protection specialist Andrey Alexandrov jointly lead the practice.

Komarevski Dimitrov & Partners, Attorneys-at-Law‘s client portfolio includes pharmaceutical manufacturers, distributors, pharmacies, biotechnology companies and food manufacturers. The firm provides day-to-day assistance to longstanding clients such as AstraZeneca which covers regulatory, employment, data protection and pricing matters, and has recently advised on the distribution of medical supplies, structuring contracts and clinical trials. Ilya Komarevski leads the team and is frequently provides regulatory advice to clients as well as representation in court in regulatory appeals.

Murgova & Partners Attorneys at Law excels in the healthcare and life sciences field due to the specialised lawyers comprising the team. Practice co-head Petya Murgova has experience in public procurement procedures relating to pharmaceuticals, medical legislation and medical malpractice cases; she is supported by co-heads Alexander Stoimenov and Simeon Krastev. The team also frequently advises state hospitals, private healthcare companies and medical centres on clinical trial requirements and developing digital healthcare services.

Penkov, Markov & Partners is well versed in advising on the regulations surrounding medicinal products, clinical trials, the distribution of food supplements and healthcare products, enabling the team to assist clients ranging from small domestic companies through to multinational players with day-to-day matters. Roman Stoyanov leads the practice and extends the team's offering to include representation in pharma litigation and healthcare-related disputes.

Schoenherr leverages its presence in Central and Eastern Europe to advise a variety of clients, including healthcare and pharmaceutical companies and manufacturers and retailers of cosmetics, detergents and food, on cross-border M&A transactions, corporate financing, regulatory issues and e-health, as well as day-to-day legal matters spanning a number of practice areas. Elena Todorova leads the team and frequently advises food and pharma companies on compliance with the regulatory framework.

Multinational pharmaceutical manufacturers and distributers, as well as individual healthcare practitioners and pharmacists, make up Stoeva, Tchompalov & Znepolski‘s client roster. The team advises clients on new pharma regulations and public procurement procedures and provides ongoing legal support to long-term clients on corporate, commercial, labour and data protection matters. Irina Stoeva leads the practice and advises global pharma and healthcare companies such as GlaxoSmithKline and Perrigo.

Wolf Theiss is well placed to advise clients across Central and Eastern Europe, including leading international pharmaceutical companies, clinical trial providers and manufacturers of medical devices, on various corporate, employment, real estate and data protection matters, as well as on cross-border acquisitions. Anna Rizova is the practice head and is supported by Hristina Dzhevlekova.